NEWS ARTICLES

Germany, Other Nations Renew Focus on Climate

During the pandemic, a number of environmental problems seemed to get better – clouds of smog over China disappeared, and urbanites in India got a new view of the Himalayan Mountains after the air quality improved. Now that the world is opening up again, many countries are putting climate at the forefront of policy. 

After 16 years under the leadership of Angela Merkel, for example,...

First Private 5G Launched in USA

Verizon Business launched its first commercially available private 5G network in the USA to offer high-speed connectivity. Private 5G networks remove the need for businesses to jostle for speed with others on a public network and help enable data-intensive applications that use computer vision, augmented reality and machine learning to increase productivity.

"You can go up to four...

GameStop Brings in New Blood to Lead

GameStop appointed two Amazon veterans as its new top executives, shortly after private-equity investor Ryan Cohen was voted the company’s chairman of the board.

The videogame retailer that became one of the most recognizable names among “meme stocks” also surprised Wall Street with a first-quarter revenue beat, a smaller-than-expected quarterly loss, and plans sell more stock to...

When Do We Need COVID-19 Boosters?

More and more of the world is getting one of the COVID-19 vaccines, and now many people are turning their attention to how long their protection will last.

For now, scientists are asking a lot of questions about Covid-19 booster shots, but they don’t yet have many answers. The National Institutes of Health recently announced that it has begun a new clinical trial of people fully vaccinated...

New Alzheimer’s Drug Approved in USA

US regulators have approved Biogen's aducanumab as the first treatment to attack a likely cause of Alzheimer's disease, sending its shares soaring, despite controversy over whether the clinical evidence proves the drug works.

Biogen said it has priced the drug, to be sold as Aduhelm, at $56,000 per year. Its shares jumped nearly 52% to $434.52 when trading resumed following the approval....

UA Plans to Buy Supersonic Planes

United Airlines is planning to turn the friendly skies into the ultrafast skies with the addition of supersonic jets. The carrier announced Thursday it’s buying 15 planes from Boom Supersonic with the option to purchase 35 more at some point. 

Boom’s first commercial supersonic jet, the Overture, has not been built or certified yet. It is targeting the start of passenger service in...

Amazon Pushes Cannabis Legalisation in USA

Cannabis stock traded higher this week after Amazon effectively endorsed the sector by saying it will support the federal legalization of marijuana.

Amazon says its public policy team will actively support legislation to legalise marijuana across the USA, and would no longer test its workers for marijuana use. A growing number of US states have moved to legalize the drug, although...

Beef Plants Closed After Ransomware Attack

JBS closed slaughter plants in the U.S., Canada and Australia on Sunday after learning it was the target of a cybersecurity attack on its servers, according to the company. The sudden move rocked the industry after the three-day weekend and sparked a flurry of speculation of a possible beef and pork shortage that might send prices skyrocketing in the coming weeks.

The U.S. is already...

Oil Gets More Expensive

Oil prices rose on Tuesday, with Brent topping $70, as optimism grew over the fuel demand outlook during the summer driving season of the United States, the world’s top oil consumer.

Prices were also boosted after data from China showed that factory activity expanded at its fastest this year in May.

Tracking firm GasBuddy said Sunday’s US gasoline demand jumped 9.6 percent...

New Alzheimer’s Treatment Awaits FDA Approval

Monday, June 7 is the deadline for the U.S. Food and Drug Administration to decide whether to approve Biogen’s much-debated Alzheimer’s disease therapy, Aducanumab. The news will have enormous implications for patients and for the biotech sector.
More than six million Americans have Alzheimer’s, and it has been nearly two decades since a new treatment for the disease has been approved. Yet...